University of Duisburg-Essen Reports Findings in HIV/AIDS (Routine Data Analysis of HIV Pre-Exposure Prophylaxis Use and Rates of Sexually Transmitted Infections Since Coverage of HIV Pre-Exposure Prophylaxis by the Statutory Health Insurance …): Immune System Diseases and Conditions – HIV/AIDS

2024 AUG 19 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- New research on Immune System Diseases and Conditions - HIV/AIDS is the subject of a report. According to news reporting originating from Essen, Germany, by NewsRx correspondents, research stated, “Human immunodeficiency virus pre-exposure prophylaxis (PrEP) is considered as an effective protection against a human immunodeficiency virus (HIV) infection. However, it is still unclear, how PrEP use is associated with the incidence of sexually transmitted infections (STI) other than HIV.”

Funders for this research include Bundesministerium fur Gesundheit, Universitat Duisburg-Essen.

Our news editors obtained a quote from the research from the University of Duisburg-Essen, “PrEP became reimbursable in Germany from September 1, 2019 for persons with statutory health insurance (SHI). With the EvE-PrEP study, the Federal Ministry of Health commissioned the evaluation of the effects of the new reimbursement situation in Germany. In the presented module of the EvE-PrEP study, routine data from three large German SHI funds were analyzed in anonymized form for the period January 1, 2019 to March 31, 2020. Data were analyzed regarding: Characteristics and adherence of PrEP users, treatment success of PrEP, and changes in STI incidence rates before and since PrEP use. The cooperating SHI funds collectively covered about 52% of the overall population in Germany in 2019. A total of 7102 persons with PrEP use were included into the analysis. These were predominantly male (99%), on average 37.4 years old and a high proportion of persons lived in large cities. The average quotient of PrEP daily defined doses and assumed days on PrEP was 87%. The average STI rates normalized per 100 person-years at individual level pre PrEP did not statistically significant differ compared to since PrEP (chlamydia: 17.5 vs. 17.6, gonococcal infection: 29.1 vs. 30.7, and syphilis: 14.6 vs.13.6). A large data set was used to evaluate the introduction of PrEP as a SHI benefit in Germany. A potentially suspected increase in bacterial STI incidence rates was not found. A rather high average adherence rate was observed. The very high proportion of men and people from the largest German cities among PrEP users is striking.”

According to the news editors, the research concluded: “These results could indicate barriers to PrEP access for people at risk of HIV, especially if they are women or people living in less urban areas.”

This research has been peer-reviewed.

For more information on this research see: Routine Data Analysis of HIV Pre-Exposure Prophylaxis Use and Rates of Sexually Transmitted Infections Since Coverage of HIV Pre-Exposure Prophylaxis by the Statutory Health Insurance in Germany. Archives of Sexual Behavior, 2024. Archives of Sexual Behavior can be contacted at: Springer|plenum Publishers, 233 Spring St, New York, NY 10013, USA. (Springer - www.springer.com; Archives of Sexual Behavior - http://www.springerlink.com/content/0004-0002/)

The news editors report that additional information may be obtained by contacting Frederik Valbert, Institute for Healthcare Management and Research, University of Duisburg-Essen, Thea-Leymann-Str. 9, 45127, Essen, Germany. Additional authors for this research include Daniel Schmidt, Christian Kollan, Patrik Droge, Melanie Klein, Udo Schneider, Martin Friebe, Jurgen Wasem and Anja Neumann.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1007/s10508-024-02922-5. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

Publisher contact information for the journal Archives of Sexual Behavior is: Springer|plenum Publishers, 233 Spring St, New York, NY 10013, USA.

(Our reports deliver fact-based news of research and discoveries from around the world.)